84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]王樂,徐無忌.六味地黃丸對(duì)兔椎間盤退變模型椎間盤組織中Ⅰ、Ⅱ型膠原表達(dá)的影響[J].中醫(yī)正骨,2016,28(08):1-7.
　WANG Le,XU Wuji.Effect of Liuwei Dihuang Wan(六味地黃丸)on typeⅠandⅡcollagen expression in intervertebral disc of rabbit model of intervertebral disc degeneration[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):1-7.
點(diǎn)擊復(fù)制

六味地黃丸對(duì)兔椎間盤退變模型椎間盤組織中Ⅰ、Ⅱ型膠原表達(dá)的影響()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年08期
頁碼:
1-7
欄目:
基礎(chǔ)研究
出版日期:
2016-08-20

文章信息/Info

Title:
Effect of Liuwei Dihuang Wan(六味地黃丸)on typeⅠandⅡcollagen expression in intervertebral disc of rabbit model of intervertebral disc degeneration
作者:
王樂; 徐無忌
湖南中醫(yī)藥大學(xué)第二附屬醫(yī)院,湖南 長沙 410005
Author(s):
WANG Le; XU Wuji
The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410005,Hunan,China
關(guān)鍵詞:
椎間盤退行性變;  六味地黃丸;  膠原Ⅰ型;  膠原Ⅱ型;  兔;  動(dòng)物實(shí)驗(yàn)
Keywords:
intervertebral disc degeneration;  Liuwei Dihuang Wan;  collagen typeⅠ;  collagen typeⅡ;  rabbits;  animal experimentation
摘要:
目的:觀察六味地黃丸對(duì)兔椎間盤退變模型椎間盤組織中Ⅰ、Ⅱ型膠原表達(dá)的影響。方法:將80只新西蘭兔隨機(jī)分為空白組、假手術(shù)組、模型組和六味地黃組,每組20只。模型組、六味地黃組手術(shù)暴露L4～5和L5～6椎間隙,隨機(jī)選擇1個(gè)椎間盤注射腫瘤壞死因子α進(jìn)行椎間盤退變?cè)炷?并以咬骨鉗咬除該椎間盤上位椎體橫突進(jìn)行標(biāo)記; 假手術(shù)組經(jīng)相同手術(shù)入路暴露L4～5和L5～6椎間隙,不做任何處理后縫合; 空白組不進(jìn)行任何手術(shù)干預(yù)。造模術(shù)后3 d開始,六味地黃組按26 mg·kg-1以六味地黃膠囊混懸液灌胃,其余3組以等量生理鹽水灌胃,每天1次,共8周。分別于藥物干預(yù)開始后2、4、6、8周,從各組隨機(jī)選取5只兔子處死,模型組和六味地黃組手術(shù)取出造模椎間盤,空白組和假手術(shù)組隨機(jī)選擇L4～5或L5～6椎間盤取出。分別采用聚合酶鏈?zhǔn)椒磻?yīng)法和Western Blot法測(cè)定椎間盤組織中Ⅰ、Ⅱ型膠原的mRNA和蛋白表達(dá)水平。結(jié)果:藥物干預(yù)2、4、6、8周后,4組兔子椎間盤組織Ⅰ型膠原mRNA表達(dá)水平比較,組間差異均有統(tǒng)計(jì)學(xué)意義[(0.064 8±0.009 8),(0.068 6±0.012 7),(0.192 0±0.040 6),(0.124 6±0.012 0),F=49.752,P=0.000;(0.066 0±0.010 0),(0.077 1±0.011 8),(0.252 4±0.039 9),(0.164 1±0.018 1),F=79.537,P=0.000;(0.071 2±0.011 2),(0.089 1±0.008 1),(0.326 3±0.028 5),(0.176 3±0.015 0),F=236.726,P=0.000;(0.094 1±0.012 0),(0.155 0±0.003 8),(0.451 4±0.039 6),(0.205 8±0.018 1),F=201.055,P=0.000]; 模型組Ⅰ型膠原mRNA表達(dá)水平高于空白組、假手術(shù)組和六味地黃組(P=0.000,P=0.015,P=0.002,P=0.000; P=0.013,P=0.002,P=0.000,P=0.015; P=0.002,P=0.012,P=0.000,P=0.000)。空白組和假手術(shù)組的Ⅰ型膠原mRNA表達(dá)水平各時(shí)間點(diǎn)間比較,差異均無統(tǒng)計(jì)學(xué)意義(F=50.563,P=0.132; F=80.352,P=0.634); 模型組和六味地黃組的Ⅰ型膠原mRNA表達(dá)水平各時(shí)間點(diǎn)間比較,差異均有統(tǒng)計(jì)學(xué)意義(F=193.635,P=0.000; F=284.736,P=0.000),Ⅰ型膠原mRNA表達(dá)水平均逐漸增高(P=0.004,P=0.002,P=0.000; P=0.000,P=0.003,P=0.001)。藥物干預(yù)2、4、6、8周后,4組兔子椎間盤組織Ⅱ型膠原mRNA表達(dá)水平比較,組間差異均有統(tǒng)計(jì)學(xué)意義[(0.042 7±0.008 0),(0.041 2±0.005 8),(0.011 6±0.002 1),(0.031 7±0.005 6),F=42.696,P=0.000;(0.038 8±0.004 3),(0.037 3±0.004 3),(0.011 5±0.001 8),(0.031 1±0.003 5),F=108.110,P=0.000;(0.030 3±0.005 7),(0.025 9±0.008 3),(0.007 9±0.002 7),(0.017 2±0.002 1),F=52.436,P=0.000;(0.029 3±0.006 9),(0.023 7±0.004 6),(0.005 3±0.001 0),(0.014 8±0.001 8),F=51.375,P=0.000]; 模型組Ⅱ型膠原mRNA表達(dá)水平低于空白組、假手術(shù)組和六味地黃組(P=0.002,P=0.001,P=0.000,P=0.001; P=0.001,P=0.000,P=0.000,P=0.001; P=0.001,P=0.002,P=0.013,P=0.000)。空白組和假手術(shù)組的Ⅱ型膠原mRNA表達(dá)水平各時(shí)間點(diǎn)間比較,差異均無統(tǒng)計(jì)學(xué)意義(F=70.463,P=0.122; F=90.362,P=0.089); 模型組和六味地黃組的Ⅱ型膠原mRNA表達(dá)水平各時(shí)間點(diǎn)間比較,差異均有統(tǒng)計(jì)學(xué)意義(F=110.364,P=0.001; F=86.362,P=0.004),模型組和六味地黃組的Ⅱ型膠原mRNA表達(dá)水平均逐漸降低(P=0.002,P=0.005,P=0.003; P=0.000,P=0.001,P=0.000)。藥物干預(yù)2、4、6、8周后,4組兔子椎間盤組織Ⅰ型膠原蛋白表達(dá)水平比較,組間差異均有統(tǒng)計(jì)學(xué)意義[(0.575 9±0.135 6),(0.599 5±0.037 4),(0.620 0±0.072 0),(0.609 6±0.032 1),F=9.288,P=0.001;(0.593 9±0.108 0),(0.647 1±0.044 8),(0.807 0±0.061 6),(0.659 9±0.105 5),F=28.883,P=0.000;(0.614 0±0.224 6),(0.685 6±0.066 5),(1.129 1±0.097 4),(0.700 1±0.086 5),F=34.957,P=0.000;(0.614 8±0.139 3),(0.742 3±0.165 3),(1.322 4±0.351 7),(0.806 0±0.094 3),F=3.296,P=0.048]; 模型組Ⅰ型膠原蛋白表達(dá)水平高于空白組、假手術(shù)組和六味地黃組(P=0.000,P=0.015,P=0.002,P=0.000; P=0.013,P=0.002,P=0.000,P=0.015; P=0.002,P=0.012,P=0.000,P=0.000)。空白組和假手術(shù)組的Ⅰ型膠原蛋白表達(dá)水平各時(shí)間點(diǎn)間比較,差異均無統(tǒng)計(jì)學(xué)意義(F=37.485,P=0.365; F=10.376,P=0.583); 模型組和六味地黃組的Ⅰ型膠原蛋白表達(dá)水平各時(shí)間點(diǎn)間比較,差異均有統(tǒng)計(jì)學(xué)意義(F=70.362,P=0.000; F=6.375,P=0.001),模型組和六味地黃組的Ⅰ型膠原蛋白表達(dá)水平均逐漸增高(P=0.005,P=0.002,P=0.000; P=0.004,P=0.001,P=0.000)。藥物干預(yù)2、4、6、8周后,4組兔子椎間盤組織Ⅱ型膠原蛋白表達(dá)水平比較,組間差異均有統(tǒng)計(jì)學(xué)意義[(0.605 8±0.066 5),(0.550 0±0.117 9),(0.278 0±0.053 2),(0.498 6±0.149 1),F=10.224,P=0.001;(0.553 7±0.126 5),(0.523 4±0.078 4),(0.258 2±0.037 8),(0.479 7±0.090 8),F=11.627,P=0.000;(0.546 8±0.120 8),(0.494 8±0.139 8),(0.219 0±0.099 2),(0.440 5±0.052 7),F=13.543,P=0.003;(0.494 8±0.042 5),(0.433 7±0.061 9),(0.131 9±0.012 8),(0.392 9±0.107 0),F=13.979,P=0.000]; 模型組Ⅱ型膠原蛋白表達(dá)水平低于空白組、假手術(shù)組和六味地黃組(P=0.002,P=0.001,P=0.000,P=0.001; P=0.001,P=0.000,P=0.000,P=0.001; P=0.001,P=0.002,P=0.013,P=0.000)。空白組和假手術(shù)組的Ⅱ型膠原蛋白表達(dá)水平各時(shí)間點(diǎn)間比較,差異均無統(tǒng)計(jì)學(xué)意義(F=17.364,P=0.092; F=15.573,P=0.175); 模型組和六味地黃組的Ⅱ型膠原蛋白表達(dá)水平各時(shí)間點(diǎn)間比較,差異均有統(tǒng)計(jì)學(xué)意義(F=17.753,P=0.001; F=13.674,P=0.000),模型組和六味地黃組的Ⅱ型膠原蛋白表達(dá)水平均逐漸降低(P=0.002,P=0.004,P=0.001; P=0.000,P=0.001,P=0.000)。結(jié)論:六味地黃丸能適度下調(diào)兔椎間盤退變模型椎間盤組織中Ⅰ型膠原的表達(dá)、上調(diào)Ⅱ型膠原的表達(dá),可在一定程度上延緩椎間盤退變進(jìn)程。
Abstract:
Objective:To observe the effect of Liuwei Dihuang Wan(六味地黃丸,LWDHW)on typeⅠandⅡcollagen expression in intervertebral disc of rabbit model of intervertebral disc degeneration.Methods:Eighty New Zealand rabbits were randomly divided into blank group,sham-operated group,model group and LWDHW group,20 cases in each group.The surgeries were performed on rabbits in model group and LWDHW group to expose L4/L5 and L5/L6 intervertebral space,and tumor necrosis factor α were injected into L4/L5 or L5/L6 intervertebral disc randomly to build intervertebral disc degeneration model.Then the intervertebral disc was labeled by removing the transverse process of upper vertebrae with rongeur.The rabbits in sham-operated group were treated with sham-operation,while the rabbits in blank group were not given any surgical intervention.Since the 3rd day after the modeling operation,the rabbits in LWDHW group were intragastric administrated with LWDH suspension in dosages of 26 mg/kg while the rabbits in other 3 groups were intragastric administrated with normal saline,once a day for 8 weeks.At 2,4,6 and 8 weeks after the beginning of drug intervention,5 rabbits were randomly selected from each group and were executed,and the intervertebral discs were fetched out.The mRNA and protein expression levels of typeⅠandⅡcollagen in intervertebral disc were measured by using polymerase chain reaction(PCR)and Western Blot assays.Results:There was statistical difference in the mRNA expression levels of typeⅠcollagen in intervertebral disc between the 4 groups at 2,4,6 and 8 weeks after the beginning of drug intervention(0.064 8+/-0.009 8,0.068 6+/-0.012 7,0.192 0+/-0.040 6,0.124 6+/-0.012 0,F=49.752,P=0.000; 0.066 0+/-0.010 0,0.077 1+/-0.011 8,0.252 4+/-0.039 9,0.164 1+/-0.018 1,F=79.537,P=0.000; 0.071 2+/-0.011 2,0.089 1+/-0.008 1,0.326 3+/-0.028 5,0.176 3+/-0.015 0,F=236.726,P=0.000; 0.094 1+/-0.012 0,0.155 0+/-0.003 8,0.451 4+/-0.039 6,0.205 8+/-0.018 1,F=201.055,P=0.000).The mRNA expression levels of typeⅠcollagen were higher in model group compared to blank group,sham-operated group and LWDHW group(P=0.000,P=0.015,P=0.002,P=0.000; P=0.013,P=0.002,P=0.000,P=0.015; P=0.002,P=0.012,P=0.000,P=0.000).There was no statistical difference in mRNA expression levels of typeⅠcollagen between different time points in blank group and sham-operated group(F=50.563,P=0.132; F=80.352,P=0.634).There was statistical difference in mRNA expression levels of typeⅠcollagen between different time points in model group and LWDHW group(F=193.635,P=0.000; F=284.736,P=0.000),and the mRNA expression levels of typeⅠcollagen increased gradually(P=0.004,P=0.002,P=0.000; P=0.000,P=0.003,P=0.001).There was statistical difference in the mRNA expression levels of typeⅡcollagen in intervertebral disc between the 4 groups at 2,4,6 and 8 weeks after the beginning of the drug intervention(0.042 7+/-0.008 0,0.041 2+/-0.005 8,0.011 6+/-0.002 1,0.031 7+/-0.005 6,F=42.696,P=0.000; 0.038 8+/-0.004 3,0.037 3+/-0.004 3,0.011 5+/-0.001 8,0.031 1+/-0.003 5,F=108.110,P=0.000; 0.030 3+/-0.005 7,0.025 9+/-0.008 3,0.007 9+/-0.002 7,0.017 2+/-0.002 1,F=52.436,P=0.000; 0.029 3+/-0.006 9,0.023 7+/-0.004 6,0.005 3+/-0.001 0,0.014 8+/-0.001 8,F=51.375,P=0.000).The mRNA expression levels of typeⅡcollagen were lower in model group compared to blank group,sham-operated group and LWDHW group(P=0.002,P=0.001,P=0.000,P=0.001; P=0.001,P=0.000,P=0.000,P=0.001; P=0.001,P=0.002,P=0.013,P=0.000).There was no statistical difference in mRNA expression levels of typeⅡcollagen between different time points in blank group and sham-operated group(F=70.463,P=0.122; F=90.362,P=0.089).There was statistical difference in mRNA expression levels of typeⅡcollagen between different time points in model group and LWDHW group(F=110.364,P=0.001; F=86.362,P=0.004),and the mRNA expression levels of typeⅡcollagen decreased gradually in model group and LWDHW group(P=0.002,P=0.005,P=0.003; P=0.000,P=0.001,P=0.000).There was statistical difference in the protein expression levels of typeⅠcollagen in intervertebral disc between the 4 groups at 2,4,6 and 8 weeks after the beginning of the drug intervention(0.575 9+/-0.135 6,0.599 5+/-0.037 4,0.620 0+/-0.072 0,0.609 6+/-0.032 1,F=9.288,P=0.001; 0.593 9+/-0.108 0,0.647 1+/-0.044 8,0.807 0+/-0.061 6,0.659 9+/-0.105 5,F=28.883,P=0.000; 0.614 0+/-0.224 6,0.685 6+/-0.066 5,1.129 1+/-0.097 4,0.700 1+/-0.086 5,F=34.957,P=0.000; 0.614 8+/-0.139 3,0.742 3+/-0.165 3,1.322 4+/-0.351 7,0.806 0+/-0.094 3,F=3.296,P=0.048).The protein expression levels of typeⅠcollagen were higher in model group compared to blank group,sham-operated group and LWDHW group(P=0.000,P=0.015,P=0.002,P=0.000; P=0.013,P=0.002,P=0.000,P=0.015; P=0.002,P=0.012,P=0.000,P=0.000).There was no statistical difference in protein expression levels of typeⅠcollagen between different time points in blank group and sham-operated group(F=37.485,P=0.365; F=10.376,P=0.583).There was statistical difference in protein expression levels of typeⅠcollagen between different time points in model group and LWDHW group(F=70.362,P=0.000; F=6.375,P=0.001),and the protein expression levels of typeⅠcollagen increased gradually in model group and LWDHW group(P=0.005,P=0.002,P=0.000; P=0.004,P=0.001,P=0.000).There was statistical difference in the protein expression levels of typeⅡcollagen in intervertebral disc between the 4 groups at 2,4,6 and 8 weeks after the beginning of the drug intervention(0.605 8+/-0.066 5,0.550 0+/-0.117 9,0.278 0+/-0.053 2,0.498 6+/-0.149 1,F=10.224,P=0.001; 0.553 7+/-0.126 5,0.523 4+/-0.078 4,0.258 2+/-0.037 8,0.479 7+/-0.090 8,F=11.627,P=0.000; 0.546 8+/-0.120 8,0.494 8+/-0.139 8,0.219 0+/-0.099 2,0.440 5+/-0.052 7,F=13.543,P=0.003; 0.494 8+/-0.042 5,0.433 7+/-0.061 9,0.131 9+/-0.012 8,0.392 9+/-0.107 0,F=13.979,P=0.000).The protein expression levels of typeⅡcollagen were lower in model group compared to blank group,sham-operated group and LWDHW group(P=0.002,P=0.001,P=0.000,P=0.001; P=0.001,P=0.000,P=0.000,P=0.001; P=0.001,P=0.002,P=0.013,P=0.000).There was no statistical difference in protein expression levels of type Ⅱcollagen between different time points in blank group and sham-operated group(F=17.364,P=0.092; F=15.573,P=0.175).There was statistical difference in protein expression levels of type Ⅱcollagen between different time points in model group and LWDHW group(F=17.753,P=0.001; F=13.674,P=0.000),and the protein expression levels of typeⅡcollagen decreased gradually in model group and LWDHW group(P=0.002,P=0.004,P=0.001; P=0.000,P=0.001,P=0.000).Conclusion:Application of LWDHW can moderately down-regulate the expression of typeⅠcollagen and up-regulate the expression of typeⅡcollagen in intervertebral disc of rabbit model of intervertebral disc degeneration,so it can postpone the degenerative process of intervertebral disc to some extent.

參考文獻(xiàn)/References:

[1] Cheung KM,Karppinen J,Chan D,et al.Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals[J].Spine(Phila Pa 1976),2009,34(9):934-940. [2] Freemont AJ.The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain[J].Rheumatology,2009,48(1):5-10. [3] 孟祥宇,夏建龍,楊挺,等.椎間盤退變的機(jī)制及修復(fù)[J].中國組織工程研究,2015,19(11):1768-1773. [4] 劉強(qiáng),張軍,張慧,等.不同腰椎扳法對(duì)椎間盤內(nèi)壓的影響[J].中醫(yī)正骨,2014,26(1):11-16. [5] Eyre DR,Muir H.Quantitative analysis of typesⅠandⅡcollagens in human intervertebral discs at various ages[J].Biochim Biophys Acta,1977,492(1):29-42. [6] Oegema TR Jr.Biochemistry of the intervertebral disc[J].Clin Sports Med,1993,12(3):419-439. [7] Walker MH,Anderson DG.Molecular basis of intervertebral disc degeneration[J].Spine J,2004,4(6 Suppl):158S-166S. [8] 呂振華,胡有谷,馮傳漢.腰椎間盤纖維性主膠原基因表達(dá)的觀察[J].中華外科雜志,1998,36(2):68-71. [9] 胡緒江,邵增務(wù).外源性腫瘤壞死因子-α對(duì)腰椎間盤退變影響的實(shí)驗(yàn)研究[J].中國脊柱脊髓雜志,2006,16(7):541-544. [10] Haschtmann D,Stoyanov JV,Ettinger L,et al.Establishment of a novel intervertebral disc/endplate culture model:analysis of an ex vivo in vitro whole-organ rabbit culture system[J].Spine(Phila Pa 1976),2006,31(25):2918-2925. [11] Molinos M,Almeida CR,Caldeira J,et al.Inflammation in intervertebral disc degeneration and regeneration[J].J R Soc Interface,2015,12(104):20141191. [12] Manfreda E,Mitteroecker P,Bookstein FL,et al.Functional morphology of the first cervical vertebra in humans and nonhuman primates[J].Anat Rec B New Anat,2006,289(5):184-194. [13] 徐無忌,李悅,原超.六味地黃丸含藥血清對(duì)椎間盤Ⅰ型和Ⅱ型膠原表達(dá)的影響[J].中國組織工程研究,2013,15(26):4857-4864.

相似文獻(xiàn)/References:

[1]張莉,秦丹霞,張細(xì)姣.腹針治療椎間盤源性腰痛[J].中醫(yī)正骨,2015,27(10):38.
[2]吳青坡,孫國紹,王林杰.后路椎管減壓聯(lián)合腰椎椎弓根釘動(dòng)態(tài)穩(wěn)定裝置內(nèi)固定 治療單節(jié)段腰椎退行性疾病[J].中醫(yī)正骨,2015,27(10):42.
[3]夏炳江,童培建.適宜中醫(yī)藥研究的椎間盤退變動(dòng)物模型的構(gòu)建[J].中醫(yī)正骨,2016,28(11):71.
[4]趙赫,高譽(yù)珊,胡振國,等.補(bǔ)腎壯筋湯對(duì)腰椎間盤退變大鼠椎間盤及行為學(xué)特征影響的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2017,29(07):12.
　ZHAO He,GAO Yushan,HU Zhenguo,et al.Effect of Bushen Zhuangjin Tang(補(bǔ)腎壯筋湯)on intervertebral disc and behavioral characteristics of rats with lumbar intervertebral disc degeneration[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):12.
[5]許勇,薛彬,孟祥超,等.伸筋活血湯對(duì)低氧誘導(dǎo)因子-1α缺失小鼠椎間盤退變的影響…[J].中醫(yī)正骨,2018,30(01):12.
　XU Yong,XUE Bin,MENG Xiangchao,et al.Effect of Shenjin Huoxue Tang(伸筋活血湯)on intervertebral disc degeneration in mice with hypoxia-inducible factor-1α deficiency[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):12.
[6]夏炳江,侯明生,張磊,等.五福飲對(duì)大鼠尾部退變椎間盤的影響及其作用機(jī)制…[J].中醫(yī)正骨,2018,30(01):18.
　XIA Bingjiang,HOU Mingsheng,ZHANG Lei,et al.Effects of Wufu Yin(五福飲)on caudal degenerative intervertebral disc in rats and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):18.
[7]刁志君,姜宏,劉錦濤,等.炎癥因子在椎間盤退變中的作用[J].中醫(yī)正骨,2018,30(07):32.
[8]梁博程,史曉林,許超,等.基于中藥系統(tǒng)藥理學(xué)方法研究六味地黃丸治療骨質(zhì)疏松癥的藥效成分、作用靶點(diǎn)及作用特點(diǎn)[J].中醫(yī)正骨,2019,31(04):1.
　LIANG Bocheng,SHI Xiaolin,XU Chao,et al.A study of pharmacodynamic components,action targets and characteristics of Liuwei Dihuang Wan(六味地黃丸)in treatment of osteoporosis using traditional chinese medicine systems pharmacology approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):1.
[9]劉汝專,張磊,潘漢升,等.中藥復(fù)方干預(yù)椎間盤退變的實(shí)驗(yàn)研究進(jìn)展[J].中醫(yī)正骨,2019,31(04):36.
[10]勞楊駿,裘一丹,徐彬,等.軸向負(fù)載誘導(dǎo)小鼠椎間盤退變模型的建立[J].中醫(yī)正骨,2019,31(05):1.
　LAO Yangjun,QIU Yidan,XU Bin,et al.A mouse model of intervertebral disc degeneration induced by axial loads[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):1.

備注/Memo

備注/Memo:
基金項(xiàng)目:國家自然科學(xué)基金青年科學(xué)基金項(xiàng)目(81302993); 湖南中醫(yī)藥科技計(jì)劃重點(diǎn)項(xiàng)目(201317) 通訊作者:王樂 E-mail:[email protected]
更新日期/Last Update: 1900-01-01